Investigating if hydroxychloroquine can prevent complications in pregnancies affected by lupus.
Official title: Can hydroxychloroquine prevent preeclampsia and preterm delivery in lupus pregnancy?
Funded at Stanford University · NIH-10889183 · Data updated 2026-11-12
This study is looking at whether taking hydroxychloroquine can help pregnant women with lupus lower their chances of developing preeclampsia and having their babies early, using information from women in the US and Sweden to find out more about how to keep them and their babies healthy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project start | August 1, 2020 |
| Project end | May 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $328,505 |
| NIH project number | 5R01AR077103-05 |
| Project ID | NIH-10889183 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are pregnant women diagnosed with systemic lupus erythematosus.
✕Less likely to help
Patients without a diagnosis of lupus or those not currently pregnant may not benefit from this research.
What this research studies
This research focuses on pregnant women with systemic lupus erythematosus and aims to determine if hydroxychloroquine (HCQ) can reduce the risk of preeclampsia and preterm delivery. The study will analyze data from large international populations, including the US and Sweden, to assess the effectiveness of HCQ in preventing adverse pregnancy outcomes. By examining prescription data and other critical factors, the research seeks to provide insights into the management of lupus during pregnancy and improve health outcomes for these patients.
Why it matters
Potential benefit: If successful, this research could lead to improved pregnancy outcomes for women with lupus, reducing the incidence of preeclampsia and preterm delivery.
How similar studies have gone: Previous pilot studies have shown promising results regarding the use of hydroxychloroquine in preventing adverse outcomes in lupus pregnancies, indicating a potential for success in this larger study.
Where this research is happening
-
Stanford University
Stanford, United States Active
Researchers
- Principal investigator: Simard, Julia F — Stanford University
- Study coordinator: Simard, Julia F
Related research
Other NIH-funded projects on the same topics.
-
Ethical, multimodal AI for predicting preeclampsia risk in early pregnancy
A data-driven AI tool uses early-pregnancy information from medical records, ultrasound, and notes to predict preeclampsia risk and support safer pregnancy care.
-
Pregnancy, lupus, and heart health in women with lupus
This study looks at how managing lupus during pregnancy can affect blood pressure and heart health for women with the disease.
-
3-D bioprinted feto-maternal tissue model to test pregnancy drugs
A high-throughput 3D tissue model of the feto-maternal interface is being built to screen drugs for safety and effectiveness in pregnancy.
-
Children's long-term health after treating chronic hypertension in pregnancy
This grant studies how giving antihypertensive medicine during pregnancy for women with chronic high blood pressure affects their children’s health as they grow up.
-
Collagen and Elastic Fibers: How the Cervix Remodels for Birth
Aims to understand how collagen and elastic fibers in the cervix change to prepare for birth, and what goes wrong in preterm birth, using mouse models and human biology clues.
-
ApoE-Tau link in preeclampsia and later brain disease
This project looks at how preeclampsia in pregnancy might connect to Alzheimer’s-related problems later in life, by studying the ApoE and Tau pathways in humans and animal models.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.